|
| |
3i3i is a world leader in private equity and venture capital.
We are active across all stages of funding. From early-stage venture capital to growth capital and buyouts, we invest €1.5bn a year in some of the most exciting and ambitious companies in the world.
We are dedicated to value creation. Our purpose is to substantially increase the value of our portfolio companies and then to realise this value, both for ourselves and for our partners, through trade sales and stock market listings. Our track record demonstrates that we have consistently achieved this - even in the toughest of bear markets.
3i's international relationship network is unique. Our team of over 300 investment professionals spans three continents, linking us to a wealth of corporate contacts and industry experts. This gives us both a local and global view of industry trends. The breadth of our network ensures that we are able to bring together the best team, with the right experience and relationships for each investment opportunity. It also means we have the scale, the agility and the talent needed to deliver even the most challenging deals.
| Contact Details: |
| 16 Palace St |
| London |
| London |
| SW1E 5JD |
| United Kingdom |
| Tel: | 44 (0)20 7928 3131 |
| Fax: | 44 (0)20 7928 0058 |
| Email: | london@3i.com |
| WWW: | www.3i.com/
|
|
Loading...
|
Recent Publications by 3i: |  |
Revisiting the hopeless ridge: Part II--Inductive orthopedic allograft applied to dental implant regeneration.
Part I of "Revisiting the Hopeless Ridge" highlighted the higher... | 4th September, 2009
| BIOMET 3i.
| Compend Contin Educ Dent. 2009 May;30(4):220-2, 224-6.
|
Treatment of an edentulous patient with CAD/CAM technology: a clinical report.
CAD/CAM (computer-aided design/computer-aided manufacturing) technology... | 7th September, 2007
| 3i Implant Innovations,
| J Prosthodont. 2007 May-Jun;16(3):200-8.
DOI Direct Link |
Psychosis: a costly by-product of social brain evolution in Homo sapiens.
The plethora of varied and often conflictual research evidence on the... | 19th August, 2006
| Department of Psychiatry, Nelson Mandela School of Medicine, University of
| Prog Neuropsychopharmacol Biol Psychiatry. 2006 Jul;30(5):797-814. Epub
DOI Direct Link |
Hurdles and opportunities for a venture capitalist investing in therapies for orphan retinal diseases.
The plethora of varied and often conflictual research evidence on the... | 2nd March, 2006
| Domain Associates, LLC, with offices in New Jersey and California, and 3i
| Retina. 2005 Dec;25(8 Suppl):S105-S108.
|
An evolutionary theory of schizophrenia: cortical connectivity, metarepresentation, and the social brain.
Schizophrenia is a worldwide, prevalent disorder with a multifactorial but... | 28th September, 2005
| Department of Psychiatry, Nelson Mandela School of Medicine, University of
| Behav Brain Sci. 2004 Dec;27(6):831-55; discussion 855-85.
|
→View more 3i research publications. |
 Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 181 times since April 2007, the link to the organisation's website has been followed 29 times Search for more companies in London Search for more companies in London This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for 3i |
